Sign In
2 Mar 2011 08:14
ο»Ώ
2 March 2011
Β
Toumaz Limited
Β
Β£1.8m raised from strategic and institutional investors
Β
Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a pioneer in low cost, ultra low power wireless communications and broadcast technology, announces that Quanta Computer Inc. (RIC: 2382.tw, 'Quanta') has increased its investment in the Group, representing a stake of 2.22% in the enlarged Group and amounted to Β£1.2m.
Β
Separately, Toumaz has also issued 7.25m shares to an institutional shareholder at 8.83p per share, representing a stake of 1.15% in the enlarged Group, and raising Β£0.6m.
Β
In total, this has raised Β£1.8m for the Group. Following admission, there will be 629,437,868 shares in issue. Application will be made for the shares to be admitted to trading on AIM on 4 March 2011.Β
Β
Quanta and Toumaz will collaborate to develop Toumaz's market leading, low power wireless healthcare and wellness technology, for use by individuals outside of the hospital environment.
Β
Toumaz also has separate strategic relationships in place for the commercialisation of Sensium based products for continuous monitoring in hospitals and on 10 February 2011, Dr. Patrick Soon-Shiong invested Β£1.3m to develop the Sensium platform for use in sport.
Β
Professor Chris Toumazou, CEO of Toumaz, commented:
Β
"The opportunity that collaborating with the world's largest laptop ODM will bring is very exciting and will be a key step towards becoming the leading technology provider for wireless healthcare.
Β
"Quanta's additional investment is a strong endorsement of our strategy of diversifying the Sensium platform beyond the hospital environment."Β
Β
Barry Lam, Chairman and CEO of Quanta, said:
Β
"We are impressed by Toumaz's technology and believe that wireless monitoring in the home will be a key area for health in the future. We look forward to working closely with Toumaz on innovative products for this growing market."
Β
Enquiries:
Β
Toumaz Holdings LimitedΒ | 020 7355 0036 |
Chris Toumazou, Chief Executive Officer | Β |
Patrick Stephansen, Chief Financial Officer | Β |
Β | Β |
FinnCap | 020 7600 1658 |
Charles Cunningham (Corporate Finance) | Β |
Brian Patient (Corporate Broking) | Β |
Β | Β |
College Hill | 020 7457 2020 |
Adrian Duffield/Rozi Morris |
Β
About ToumazΒ (www.toumaz.com)
Β
ToumazΒ is pioneering low cost, ultra-low power wireless technologiesΒ for a wide range of markets including medical monitoringΒ andΒ internet-connected consumer devices.
Β
Targeting the Healthcare market, Toumaz's licensable smart sensor interface and transceiver platform, Sensium, is a leader in real-time wireless monitoring of the body's vital signs.Β Sensium has the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connectingΒ individuals to healthcare providers -Β simply, affordably and unobtrusively.Β For healthcare professionals, this creates new opportunities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible personalised healthcare.
Β
Toumaz also uses its ultra low power expertise to design devices for wireless connectivity andΒ internet-connectedΒ consumer products. Toumaz currently supplies FM/DAB radio chips and complete modules to leaders in the digital radio market, such as PURE.Β
Β
Toumaz is an AIM listed company (AIM: TMZ)Β with developmentΒ centresΒ in Oxford, UK and Taipei City, Taiwan.
Β
Follow the stocks
